These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31493257)

  • 1. Effects of Specific Inhibitor of Phosphodiesterase 7 at the Late Stage of Long-Term Potentiation in Murine Hippocampal Slices.
    Beregovoi NA; Starostina MV; Lipina TV
    Bull Exp Biol Med; 2019 Aug; 167(4):467-469. PubMed ID: 31493257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role for cyclic guanosine 3',5'monophosphate signaling in synaptic plasticity: a selective suppressor of protein kinase A-dependent forms of long-term potentiation.
    Makhinson M; Opazo P; Carlisle HJ; Godsil B; Grant SG; O'Dell TJ
    Neuroscience; 2006 Jun; 140(2):415-31. PubMed ID: 16549271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Object memory enhancement by combining sub-efficacious doses of specific phosphodiesterase inhibitors.
    Bollen E; Akkerman S; Puzzo D; Gulisano W; Palmeri A; D'Hooge R; Balschun D; Steinbusch HW; Blokland A; Prickaerts J
    Neuropharmacology; 2015 Aug; 95():361-6. PubMed ID: 25896769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus.
    Fernández-Fernández D; Rosenbrock H; Kroker KS
    Synapse; 2015 Oct; 69(10):484-96. PubMed ID: 26178667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging.
    Navakkode S; Sajikumar S; Frey JU
    J Neurosci; 2004 Sep; 24(35):7740-4. PubMed ID: 15342741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance.
    Boess FG; Hendrix M; van der Staay FJ; Erb C; Schreiber R; van Staveren W; de Vente J; Prickaerts J; Blokland A; Koenig G
    Neuropharmacology; 2004 Dec; 47(7):1081-92. PubMed ID: 15555642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents.
    Rosenbrock H; Giovannini R; Schänzle G; Koros E; Runge F; Fuchs H; Marti A; Reymann KG; Schröder UH; Fedele E; Dorner-Ciossek C
    J Pharmacol Exp Ther; 2019 Dec; 371(3):633-641. PubMed ID: 31578258
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute stress impairs hippocampal mossy fiber-CA3 long-term potentiation by enhancing cAMP-specific phosphodiesterase 4 activity.
    Chen CC; Yang CH; Huang CC; Hsu KS
    Neuropsychopharmacology; 2010 Jun; 35(7):1605-17. PubMed ID: 20237461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
    Monfort P; Muñoz MD; Kosenko E; Felipo V
    J Neurosci; 2002 Dec; 22(23):10116-22. PubMed ID: 12451112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
    Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
    Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin A induces bidirectional modulation of synaptic plasticity: Inhibiting long-term potentiation and preventing depotentiation.
    Lu GL; Lee CH; Chiou LC
    Neuropharmacology; 2016 Aug; 107():168-180. PubMed ID: 26965217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential maintenance and frequency-dependent tuning of LTP at hippocampal synapses of specific strains of inbred mice.
    Nguyen PV; Duffy SN; Young JZ
    J Neurophysiol; 2000 Nov; 84(5):2484-93. PubMed ID: 11067991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous nitric oxide causes potentiation of hippocampal synaptic transmission during low-frequency stimulation via the endogenous nitric oxide-cGMP pathway.
    Bon CL; Garthwaite J
    Eur J Neurosci; 2001 Aug; 14(4):585-94. PubMed ID: 11556884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation of proteins during a critical time window is necessary for the maintenance of long-term potentiation in the hippocampal CA1 region.
    Matthies H; Kretlow J; Matthies H; Smalla KH; Staak S; Krug M
    Neuroscience; 1999; 91(1):175-83. PubMed ID: 10336068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FM1-43 imaging reveals cGMP-dependent long-term depression of presynaptic transmitter release.
    Stanton PK; Heinemann U; Muller W
    J Neurosci; 2001 Oct; 21(19):RC167. PubMed ID: 11567078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved long-term memory via enhancing cGMP-PKG signaling requires cAMP-PKA signaling.
    Bollen E; Puzzo D; Rutten K; Privitera L; De Vry J; Vanmierlo T; Kenis G; Palmeri A; D'Hooge R; Balschun D; Steinbusch HM; Blokland A; Prickaerts J
    Neuropsychopharmacology; 2014 Oct; 39(11):2497-505. PubMed ID: 24813825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates.
    Pu L; Bao GB; Xu NJ; Ma L; Pei G
    J Neurosci; 2002 Mar; 22(5):1914-21. PubMed ID: 11880521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal synaptic plasticity in mice carrying the rd mutation in the gene encoding cGMP phosphodiesterase type 6 (PDE6).
    Kuenzi F; Rosahl TW; Morton RA; Fitzjohn SM; Collingridge GL; Seabrook GR
    Brain Res; 2003 Mar; 967(1-2):144-51. PubMed ID: 12650975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tonic and phasic nitric oxide signals in hippocampal long-term potentiation.
    Hopper RA; Garthwaite J
    J Neurosci; 2006 Nov; 26(45):11513-21. PubMed ID: 17093072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons.
    Misner DL; Sullivan JM
    J Neurosci; 1999 Aug; 19(16):6795-805. PubMed ID: 10436037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.